31 May 2013
The Board of Smiths Group notes the recent media speculation about Smiths Medical. Smiths today confirms that it has received a preliminary approach for the Medical division. This approach may or may not lead to a transaction. Discussions are at an early stage and a further announcement will be made as appropriate.
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Smiths honoured at the London Stock Exchange
Read our latest company news as Smiths is honoured at the London Stock Exchange.
Find out more
Smiths appoints new independent Non-executive Director
Read our latest company news as the Board of Smiths is pleased to announce the appointment of Laurence Mulliez as an independent Non-executive Director, with effect from 1 September 2026.
Find out more
Smiths Group plc – Q3 trading update
Find out more
